Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Acute and chronic safety by evaluating incidence of major adverse events from baseline to one month post-procedure or six months for new renal artery stenosis
Change in systolic blood pressure as measured by 24-hour ambulatory blood pressure monitoring (ABPM) from baseline to six months post-procedure
This trial is currently recruiting. More details are available at SpyralHTNtrials.com
Disclaimer: This page may include information about products that may not be available in your region or country. Please consult the approved indications for use. Content on specific Medtronic products is not intended for users in markets that do not have authorization for use.
CAUTION. Investigational device. Limited by U.S. law to investigational use.
Measurement started after witnessed drug ingestion.